CAS NO: | 63590-64-7 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
生物活性 | Terazosin is a quinazoline derivative and a competitive and orally activeα1-adrenoceptorantagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3]. |
IC50& Target | α1-adrenoceptor[1] |
体外研究 (In Vitro) | Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells[1]. |
体内研究 (In Vivo) | Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm[3]. |
Clinical Trial | |
分子量 | 387.43 |
Formula | C19H25N5O4 |
CAS 号 | 63590-64-7 |
中文名称 | 特拉唑嗪 |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |